Peptide API CMO Market Brief Overview by PBIPosted by venkatakiran on September 18th, 2019 Peptide API CMO Market Size and Growth Rate:
“The Global Peptide API CMO Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR over seven years forecast period 2019-2025 owing to grow in incidence of cancer and other chronic life threatening diseases around the globe.” Peptide Generic API Dominates the Global peptide API CMO Market: Based on product type, global peptide API CMO market segmented into Peptide Generic API, peptide NCEs. Peptide Generic API dominated the global peptide API CMO market in 2018 and estimated to dominate over the forecast period owing to increase in prevalence of various types of cancers and other diseases, low risk in investing on these products, more profits if the product gets approved than innovation of newer protein and peptide drugs, rise in awareness about the peptide API CMO among various healthcare sectors, and patent filings by the market players are surge the market over the forecast years. However, a slow growth rate observed for the peptide NCE due to the higher investments, high risk and low profits. Browse More Insights of the report @https://www.precisionbusinessinsights.com/market-reports/global-peptide-api-cmo-market/ North America Leads the Global peptide API CMO Market:
PBI’s global peptide API CMO market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to increasing number of research activities and advancements in technologies and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Moreover, increasing prevalence of chronic diseases such as cancer, cardiovascular and autoimmune diseases and rising focus on development of new APIs are expected to drive the growth of the market. Europe and Asia Pacific region are expected to grow at a significant growth rate over the forecast years due to increased demand for the peptide and protein APIs.
Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players:
Global peptide API CMO market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. Key player’s profiled in Peptide API CMO Market are:
ScinoPharm Taiwan, Ltd. (Taiwan), Corden Pharma International (Germany), Bachem AG (Switzerland), Biopeptek Pharmaceuticals LLC. (U.S.), Hybio Pharmaceutical Co., Ltd. (China), Chinese Peptide Company (China), AmbioPharm, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), PolyPeptide Group (Sweden) and Chemi S.p.A. (Italy). Avail Sample of the report for more information of the report @https://www.precisionbusinessinsights.com/request-sample?product_id=36185 Detailed Segmentation of Peptide API CMO Market:
By Product Type o Peptide Generic API o Peptide NCEs By Therapeutic area o Oncology o Cardiovascular Disorders o metabolic Disorders o CNS Disorders o Respiratory Disorders o Gastrointestinal Disorders o Anti-infective o Dermatology o Renal Disorders o Others End User o Pharmaceutical Companies o Biopharmaceutical Companies Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
About Us: Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. Contact Us: Shreya Paul Senior Business Development Executive Email @ shreya@precisionbusinessinsights.com Call @ +1-866-598-1553 Precision Business Insights Like it? Share it! More by this author |